Non-Moderated Poster Abstract
Eposter Presentation
 
Accept format: PDF. The file size should not be more than 5MB
 
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
 
Withdrawn
Abstract
Renal Functional Outcomes in Robot-Assisted Partial Nephrectomy with Minimum Layer Resection Using Virtual Three-Dimensional Image Assistance
Non-Moderated Poster Abstract
Clinical Research
Novel Advances: Robotic Surgery
Author's Information
10
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Japan
Shuji Isotani shujiisotani@gmail.com Japan *
Tomoki Kimura to-kimura@juntendo.ac.jp Japan -
Ippei Hiramatsu ihirama@juntendo.ac.jp Japan -
Taiki Ogasa t-ogasa@juntendo.ac.jp Japan -
Tomoya Shirakawa t-shirakawa@juntendo.ac.jp Japan -
Takeshi Ieda tieda@juntendo.ac.jp Japan -
Fumitaka Shimizu f_simizu@juntendo.ac.jp Japan -
Masayoshi Nagata m-nagata@juntendo.ac.jp Japan -
Hisamitsu Ide h.ide.me@juntendo.ac.jp Japan -
Shigeo Horie shorie@juntendo.ac.jp Japan -
 
 
 
 
 
 
 
 
 
 
Abstract Content
Robot-assisted partial nephrectomy (RAPN) is a standard treatment for small renal cell carcinoma. The integration of virtual three-dimensional partial nephrectomy (3DvPN) images enhances surgical planning and intraoperative navigation. The Minimum Layer Resection (MLR) technique, guided by 3DvPN, enables precise tumor excision with minimal surgical margins, aiming to optimize both renal function preservation and oncological safety.
We retrospectively analyzed 312 patients who underwent RAPN between 2012 and 2022. Patients with less than three years of follow-up, prior renal embolization for arteriovenous malformation (AVM), radical nephrectomy, or contralateral renal surgery were excluded. The MLR technique utilized preoperative 3DvPN images to create a detailed surgical roadmap, allowing tumor resection with a 1–2 mm margin under direct vision. The primary endpoint was postoperative renal function, assessed by estimated glomerular filtration rate (eGFR) preservation at 2 weeks; 1, 3, and 6 months; and 1, 2, and 3 years. Secondary endpoints included factors associated with renal function outcomes and oncological safety.
At 3 months postoperatively, 91.0% of patients retained >90% of baseline eGFR, and 84.4% did so at 3 years. Short-term renal function (1 month) was significantly influenced by tumor size, warm ischemia time (WIT), blood loss, and application of MLR. Long-term function (3 years) was affected by tumor size, WIT, RENAL score, blood loss, and use of the MLR technique. Compared with conventional resection approaches, MLR was associated with superior renal function preservation. Notably, no increase in positive surgical margins or local recurrence was observed, supporting its oncological safety.
RAPN with 3DvPN-guided MLR enables precise tumor excision while preserving renal function both in the short and long term.This technique provides an effective balance between oncological control and functional outcomes, representing a promising advancement in nephron-sparing surgery.
RAPN renal function 3D
 
 
 
 
 
 
 
 
 
 
1732
 
Presentation Details